Danaher Corporation (DHR) Holdings Maintained by Gamble Jones Investment Counsel
Gamble Jones Investment Counsel continued to hold its stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,355 shares of the conglomerate’s stock at the close of the 2nd quarter. Gamble Jones Investment Counsel’s holdings in Danaher Corporation were worth $536,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. BlackRock Inc. grew its holdings in shares of Danaher Corporation by 2,530.9% in the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after purchasing an additional 36,524,795 shares during the period. Flossbach Von Storch AG grew its holdings in shares of Danaher Corporation by 44.7% in the second quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after purchasing an additional 1,785,810 shares during the period. Vanguard Group Inc. grew its holdings in shares of Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after purchasing an additional 1,530,015 shares during the period. MARSHALL WACE ASIA Ltd purchased a new stake in shares of Danaher Corporation in the first quarter valued at about $116,462,000. Finally, Marshall Wace North America L.P. purchased a new stake in shares of Danaher Corporation in the first quarter valued at about $116,462,000. 75.75% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Danaher Corporation (DHR) Holdings Maintained by Gamble Jones Investment Counsel” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/11/danaher-corporation-dhr-holdings-maintained-by-gamble-jones-investment-counsel.html.
A number of equities research analysts recently issued reports on the stock. J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a report on Friday, July 28th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $92.72.
Shares of Danaher Corporation (NYSE:DHR) opened at 86.76 on Monday. The firm has a market cap of $60.27 billion, a PE ratio of 27.69 and a beta of 1.03. The stock’s 50 day moving average is $81.87 and its 200 day moving average is $84.14. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the previous year, the business earned $0.90 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider William King sold 7,458 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock valued at $5,916,223 in the last quarter. Company insiders own 12.20% of the company’s stock.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.